Is Indraprastha Medical Corporation Ltd debt-free?

Yes, Indraprastha Medical Corporation Ltd is debt-free with a debt-to-equity ratio of 0.05.

Home

Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation Ltd Financials

Indraprastha Medical Corporation Ltd Financial Statement

Indraprastha Medical Corporation Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Jun 2025	Mar 2025	Dec 2024
Revenue	371.96	340.10	330.06
Operating Expense	291.91	272.43	272.74
Net Profit	51.46	41.01	32.81
Net Profit Margin	13.83	12.06	9.94
Earning Per Share	5.61	4.47	3.58
EBIDTA	80.63	70.51	57.47
Effective Tax Rate	21.77	25.27	20.71

Particulars	Jun 2025
Revenue	371.96
Operating Expense	291.91
Net Profit	51.46
Net Profit Margin	13.83
Earning Per Share	5.61
EBIDTA	80.63
Effective Tax Rate	21.77

Indraprastha Medical Corporation Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	1,356.36	1,244.70	1,098.67
Operating Expenses Annual	1,112.09	1,051.34	947.97
Operating Profit Annual	266.92	210.25	160.73
Interest Annual	6.27	4.06	4.28
Depreciation	43.87	39.46	39.27
Net Profit Annual	160.99	123.96	86.15
Tax Annual	55.33	42.15	31.03

Particulars	Mar 2025
Total Revenue Annual	1,356.36
Operating Expenses Annual	1,112.09
Operating Profit Annual	266.92
Interest Annual	6.27
Depreciation	43.87
Net Profit Annual	160.99
Tax Annual	55.33

Indraprastha Medical Corporation Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	61.60	52.26	41.74
Cash Flow from Operations	156.75	200.15	144.47
Cash Flow from Investing	-110.99	-158.43	-107.91
Cash Flow from Financing	-45.88	-32.38	-26.04
Cash Flow at the End	61.48	61.60	52.26

Particulars	Mar 2025
Cash Flow at the Beginning	61.60
Cash Flow from Operations	156.75
Cash Flow from Investing	-110.99
Cash Flow from Financing	-45.88
Cash Flow at the End	61.48

Indraprastha Medical Corporation Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	19.68	16.89	14.63
PBIT Margin (%)	16.41	13.67	11.06
PBT Margin (%)	13.79	10.30	8.48
Net PROFIT Margin (%)	11.87	9.96	7.84
Return On Networth / Equity (%)	29.97	28.92	24.44
Return On Networth /Employed (%)	37.11	35.91	32.14
Return On Assets (%)	26.82	26.19	22.82
Total Debt / Equity (X)	0.06	0.04	0.01
Asset Turnover Ratio (%)	2.26	2.63	2.91

Particulars	Mar 2025
PBDIT Margin (%)	19.68
PBIT Margin (%)	16.41
PBT Margin (%)	13.79
Net PROFIT Margin (%)	11.87
Return On Networth / Equity (%)	29.97
Return On Networth /Employed (%)	37.11
Return On Assets (%)	26.82
Total Debt / Equity (X)	0.06
Asset Turnover Ratio (%)	2.26

Indraprastha Medical Corporation Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	328.06	346.94	275.05
Total Current Assets Annual	431.13	307.98	223.08
Non Current Assets Annual	420.49	415.26	332.06
Total Shareholders Funds Annual	596.68	477.76	379.45
Total Assets Annual	851.62	723.24	555.14

Particulars	Mar 2025
Fixed Assets Annual	328.06
Total Current Assets Annual	431.13
Non Current Assets Annual	420.49
Total Shareholders Funds Annual	596.68
Total Assets Annual	851.62

Indraprastha Medical Corporation Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Indraprastha Medical Corporation Ltd Financials

As of Sep 16, 2025, Indraprastha Medical Corporation Ltd has a market capitalization of 3,539.04 Cr. Value Research classifies it as a Mid-Cap company.

Yes, Indraprastha Medical Corporation Ltd is with a debt-to-equity ratio of 0.05.

In FY 2024 , Indraprastha Medical Corporation Ltd recorded a total revenue of approximately 1,356.36 Cr marking a significant milestone in the company's financial performance.

Indraprastha Medical Corporation Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.8% and 0.1% annually, respectively..

Indraprastha Medical Corporation Ltd's current PE ratio is 21.98.

Indraprastha Medical Corporation Ltd's ROCE averaged 33.4% from the FY ending March 2023 to 2025, with a median of 33.2%. It peaked at 35.3% in March 2025, reflecting strong capital efficiency over the period..

Indraprastha Medical Corporation Ltd's latest EBIT is Rs. 222.59 Cr, surpassing the average EBIT of Rs. 171.41 Cr over the 5 years..